These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25777527)

  • 41. Prediction of cytochrome P450 mediated metabolism.
    Olsen L; Oostenbrink C; Jørgensen FS
    Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applications.
    Afzelius L; Arnby CH; Broo A; Carlsson L; Isaksson C; Jurva U; Kjellander B; Kolmodin K; Nilsson K; Raubacher F; Weidolf L
    Drug Metab Rev; 2007; 39(1):61-86. PubMed ID: 17364881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WhichCyp: prediction of cytochromes P450 inhibition.
    Rostkowski M; Spjuth O; Rydberg P
    Bioinformatics; 2013 Aug; 29(16):2051-2. PubMed ID: 23740742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals.
    Rendic S; Guengerich FP
    Chem Res Toxicol; 2015 Jan; 28(1):38-42. PubMed ID: 25485457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm.
    Gelboin HV; Krausz K
    J Clin Pharmacol; 2006 Mar; 46(3):353-72. PubMed ID: 16490812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CypReact: A Software Tool for in Silico Reactant Prediction for Human Cytochrome P450 Enzymes.
    Tian S; Djoumbou-Feunang Y; Greiner R; Wishart DS
    J Chem Inf Model; 2018 Jun; 58(6):1282-1291. PubMed ID: 29738669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
    Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Xenobiotic toxicity prediction combined with xenobiotic metabolism prediction in the human body].
    Rudik AV; Dmitriev AV; Lagunin AA; Ivanov SM; Filimonov DA; Poroikov VV
    Biomed Khim; 2019 Feb; 65(2):114-122. PubMed ID: 30950816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CypRules: a rule-based P450 inhibition prediction server.
    Shao CY; Su BH; Tu YS; Lin C; Lin OA; Tseng YJ
    Bioinformatics; 2015 Jun; 31(11):1869-71. PubMed ID: 25617412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Research progress of zebrafish used in drug metabolism].
    Chen QX; Zeng S
    Yao Xue Xue Bao; 2011 Sep; 46(9):1026-31. PubMed ID: 22121770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FAst MEtabolizer (FAME): A rapid and accurate predictor of sites of metabolism in multiple species by endogenous enzymes.
    Kirchmair J; Williamson MJ; Afzal AM; Tyzack JD; Choy AP; Howlett A; Rydberg P; Glen RC
    J Chem Inf Model; 2013 Nov; 53(11):2896-907. PubMed ID: 24219364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ligand-based models for the isoform specificity of cytochrome P450 3A4, 2D6, and 2C9 substrates.
    Terfloth L; Bienfait B; Gasteiger J
    J Chem Inf Model; 2007; 47(4):1688-701. PubMed ID: 17608404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Constructing xenobiotic maps of metabolism to predict enzymes catalyzing metabolites capable of binding to DNA.
    Conan M; Théret N; Langouet S; Siegel A
    BMC Bioinformatics; 2021 Sep; 22(1):450. PubMed ID: 34548010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GLORY: Generator of the Structures of Likely Cytochrome P450 Metabolites Based on Predicted Sites of Metabolism.
    de Bruyn Kops C; Stork C; Šícho M; Kochev N; Svozil D; Jeliazkova N; Kirchmair J
    Front Chem; 2019; 7():402. PubMed ID: 31249827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and validation of an in silico P450 profiler based on pharmacophore models.
    Schuster D; Laggner C; Steindl TM; Langer T
    Curr Drug Discov Technol; 2006 Mar; 3(1):1-48. PubMed ID: 16712462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a computational tool to rival experts in the prediction of sites of metabolism of xenobiotics by p450s.
    Campagna-Slater V; Pottel J; Therrien E; Cantin LD; Moitessier N
    J Chem Inf Model; 2012 Sep; 52(9):2471-83. PubMed ID: 22916680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes.
    Olesen OV; Linnet K
    Pharmacology; 1997 Nov; 55(5):235-43. PubMed ID: 9399333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computational Prediction of Site of Metabolism for UGT-Catalyzed Reactions.
    Cai Y; Yang H; Li W; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2019 Mar; 59(3):1085-1095. PubMed ID: 30586295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.